Unlocking Cancer Therapies: Ethyl 4-Methyl-3-((4-(Pyridin-3-yl)Pyrimidin-2-yl)Amino)Benzoate
Discover the critical role of this high-purity intermediate in the synthesis of life-saving cancer drugs, particularly Nilotinib. Explore its chemical significance and why reliable sourcing is paramount for pharmaceutical innovation.
Get a Quote & SampleProduct Core Value
Ethyl 4-methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)benzoate
This compound is a vital pharmaceutical intermediate, recognized for its crucial role in the synthesis of Nilotinib, a key drug used in the treatment of Chronic Myelogenous Leukemia (CML). As a leading supplier in China, we ensure the highest purity standards for this essential building block, supporting advanced pharmaceutical R&D and production.
- Discover the precision required for Nilotinib intermediate synthesis, where high purity is non-negotiable for effective cancer therapies.
- Explore the chemical structure of Ethyl 4-methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)benzoate, a testament to meticulous organic chemistry.
- Understand the importance of reliable pharmaceutical intermediates for CML treatment, ensuring patient safety and drug efficacy.
- Learn about the quality control measures essential for producing this pyrimidine derivative synthesis, a cornerstone for advanced drug development.
Key Advantages
Exceptional Purity
Our commitment to producing Ethyl 4-methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)benzoate with a purity of ≥98.0% ensures your synthesis processes are robust and yield optimal results, critical for pharmaceutical intermediates.
Crucial for Nilotinib
This compound is a cornerstone in the synthesis of Nilotinib, directly impacting the efficacy of treatments for conditions like Chronic Myelogenous Leukemia.
Reliable Manufacturing
Leveraging advanced production techniques, we stand as a trusted manufacturer in China, providing consistent quality for this essential pyrimidine derivative.
Key Applications
Nilotinib Synthesis
The primary application of this intermediate is in the complex synthesis pathway of Nilotinib, a vital drug for treating CML.
Pharmaceutical R&D
Researchers utilize this compound in drug discovery and development for novel targeted therapies, leveraging its unique chemical structure.
Targeted Therapy Development
Its role extends to the broader development of targeted therapies, focusing on kinase inhibitors and similar complex molecules.
Advanced Organic Synthesis
Chemists employ this compound as a key building block in intricate organic synthesis projects requiring precise molecular construction.